Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPD
Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPD
Not yet recruiting · NCT07425210 · Registry updated 2026-02-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPD | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Not yet recruiting | Phase 2 | 2026-02-25 | NCT07425210 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Haisco Pharmaceutical Group Co., Ltd. | 50 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Guizhou Provincial People's Hospital | Guiyang | China | 24 |